| Nov 18 |
Amylyx Pharmaceuticals upgraded to Outperform at Baird, shares rise
|
| Nov 9 |
Amylyx Pharmaceuticals, Inc. (AMLX) Q3 2024 Earnings Call Transcript
|
| Nov 9 |
Amylyx Pharmaceuticals Third Quarter 2024 Earnings: US$1.07 loss per share (vs US$0.31 profit in 3Q 2023)
|
| Nov 8 |
Amylyx Pharmaceuticals Inc (AMLX) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ...
|
| Nov 8 |
Q3 2024 Amylyx Pharmaceuticals Inc Earnings Call
|
| Nov 7 |
Amylyx Pharmaceuticals Reports Third Quarter 2024 Financial Results
|
| Nov 4 |
Amylyx Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 7, 2024
|
| Oct 26 |
Perceptive Advisors LLC's Strategic Acquisition in Amylyx Pharmaceuticals Inc
|
| Oct 23 |
Amylyx upgraded to buy by BofA on hypoglycemia drug potential
|
| Oct 21 |
October 2024's US Penny Stocks Poised For Growth
|
